Otogenetics corporation:1186613 [20-004046]
Ended Purchase Order Awarded Last action
- Contract number
- 75N92B20P00059
- Awardee
-
Otogenetics Corporation UEI TN78B1GJRWR8
- Awarding agency
-
National Insititue of Arthritis and Musculoskeletal and Skin Diseases
National Institutes of Health, Department of Health and Human Services
- Obligated
- $24,773
Award facts
- Contract value 100% obligated
- $24,773.00 Current and potential, with all options
- Completion date
- Current and potential, with all options
- NAICS code
- 621511 Medical Laboratories
- PSC
- Q301 Reference Laboratory Testing
- Set-aside
- No set-aside
- Competition
- Not Competed under SAP · 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Bethesda, MD 20892, USA
Award details come from SAM.gov/FPDS.
About this award
The National Institute of Arthritis and Musculoskeletal and Skin Diseases awarded a purchase order to Otogenetics Corporation for $24,773.00 on September 5, 2020. Performance occurs in Bethesda, Maryland. The order procures next-generation sequencing laboratory services, including whole exome sequencing and clinical genetic testing to support research programs within the National Institutes of Health. The contract is firm fixed price with no set-aside applied.
Quick answers
Who was awarded contract 75N92B20P00059?
75N92B20P00059 was awarded to Otogenetics Corporation by National Insititue of Arthritis and Musculoskeletal and Skin Diseases (National Institutes of Health) on September 5, 2020.
How much is contract 75N92B20P00059 worth?
The government has obligated $24,773 on 75N92B20P00059.
Was contract 75N92B20P00059 competed?
The extent of competition for 75N92B20P00059 was not competed under sap. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award